NCT00284076View on ClinicalTrials.gov

L-Arginine in the Treatment of Peripheral Arterial Disease

NACompletedINTERVENTIONAL
Timeline

Start Date

February 29, 2000

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions
Cardiovascular DiseasesPeripheral Vascular Diseases
Interventions
DRUG

L-arginine

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Stanford University

OTHER

NCT00284076 - L-Arginine in the Treatment of Peripheral Arterial Disease | Biotech Hunter | Biotech Hunter